In-vitro sensitivity of Elavobacterium meningosepticum to antimicrobial agents.
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002509:Cephaloridine / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003091:Colistin / Q000494:pharmacology; D004096:Dihydrostreptomycin Sulfate / Q000494:pharmacology; D004357:Drug Synergism; D004917:Erythromycin / Q000494:pharmacology; D005417:Flavobacterium / Q000187:drug effects*; D005493:Folic Acid Antagonists / Q000494:pharmacology; D005839:Gentamicins / Q000494:pharmacology; D007612:Kanamycin / Q000494:pharmacology; D008034:Lincomycin / Q000494:pharmacology; D008712:Methicillin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D013420:Sulfamethoxazole / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D005493:Folic Acid Antagonists; D005839:Gentamicins; D010406:Penicillins; D011743:Pyrimidines; D009675:Novobiocin; D009268:Nalidixic Acid; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D014640:Vancomycin; D000667:Ampicillin; D008034:Lincomycin; D013752:Tetracycline; D013420:Sulfamethoxazole; D002509:Cephaloridine; D008712:Methicillin; D004096:Dihydrostreptomycin Sulfate; D012293:Rifampin; D003091:Colistin